US spot Bitcoin ETFs recorded $95 million in net outflows on November 10, marking the fourth consecutive day of withdrawals. BlackRock's iShares Bitcoin Trust led with $78.2 million in outflows, followed by Fidelity's Wise Origin Bitcoin Fund with $36.8 million. Despite some inflows into the Hashdex Bitcoin ETF, overall selling pressure continues, coinciding with Bitcoin's price dropping to around $73,810. This trend suggests institutional investors remain cautious, though the smaller recent outflow hints at easing pressure. Bitcoin's ability to hold above $73,000 will be key to regaining momentum.
Bitcoin ETF outflows totaled $95 million on November 10, led by BlackRock's $78.2 million withdrawal. For readers following cryptocurrency markets, here is Pluang's snapshot as of Nov 11, 2026 16:21 WIB: out of 50 major cryptocurrencies, 8 rose and 41 fell. Notable movers include SAND at Rp766 (-2.90%), DOGE at Rp1.223 (-2.70%), and SOL at Rp1.498.433 (-2.68%), with varied Pluang order activity and typical hold times.
Rakuten Kobo's 2026 annual report highlights a shift in global reading habits towards niche communities and diverse genres like sports romances, dark romance, and cozy mysteries. The report notes the fragmentation of traditional bestseller lists as r...
Anthropic, an AI company, is reserving up to 20% of its initial public offering (IPO) shares specifically for retail investors. This allocation is significantly higher than the typical 5% to 10% usually offered to individual investors in IPOs. By doi...
DataParser by 17a-4 LLC now supports capturing Zoom AI meeting summaries along with transcripts and recordings for regulatory compliance. This solution helps firms retain, supervise, and search AI-generated content, closing gaps in archiving platform...
At the 9th China International Import Expo (CIIE), Shanghai Zhenhua Heavy Industries (ZPMC) signed import procurement contracts worth RMB 2.835 billion with 12 overseas suppliers including Siemens and ABB. This brings ZPMC's cumulative procurement co...
Devia, an AI platform spun out from Visium, has launched to help biopharma companies, CDMOs, and CROs manage GxP quality deviations more efficiently. It automates the entire deviation lifecycle from reporting to root cause analysis and CAPA, reducing...
